Actively Recruiting
Reliability Evaluation of Intraocular Pressure One Day After Vitreoretinal Surgery Comparing Goldmann Applanation Tonometry to Icare and Accupen
Led by CHU de Quebec-Universite Laval · Updated on 2024-09-26
67
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the accuracy of two portable instruments, Icare and Accupen, for measuring intraocular pressure (IOP) compared to the gold standard, Goldmann applanation tonometry (GAT), one day after vitreoretinal surgery. The study aims to determine if these simpler, easier-to-use methods provide reliable IOP measurements in post-operative patients, helping to potentially replace the more cumbersome GAT method. This prospective controlled study enrolls 67 patients who have undergone vitreoretinal surgery. Participants will have their IOP measured using three devices: GAT, Icare, and Accupen, in a randomized order during their one-day post-operative visit. A resident ophthalmologist will perform two pressure measurements with each device and calculate the average for comparison. The study focuses on verifying if the portable methods match the accuracy of GAT in this surgical context. During the single post-operative visit, medical history related to the eye surgery and diagnosis will be recorded. The main outcome is to assess the agreement of IOP measurements among the three devices one day after surgery. The study will also evaluate the reliability and validity of the portable devices across different pressure levels. Participation involves this one-time measurement and medical review, with no long-term follow-up required.
CONDITIONS
Brief Title
Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Have received vitreoretinal surgery
You will not qualify if you...
- Corneal dystrophy
- Corneal surgery such as penetrating keratoplasty or DSAEK/DMEK within the last 6 months
- Irregular corneal surface
- Active corneal ulcer
- Active epithelial deficit
- Central corneal scarring
- History of scleral buckle surgery on the eye involved
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo vitreoretinal surgery followed by immediate post-operative care.
1 post-operative visit (in-person)
Trial Site Locations
Total: 1 location
1
Hôpital du Saint-Sacrement, CHU de Québec - Université Laval
Québec, Quebec, Canada, G1S4L8
Actively Recruiting
Research Team
J
Julie Mauger, BSc
S
Sébastien Méthot, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here